Regressing SARS-CoV-2 Sewage Measurements Onto COVID-19 Burden in the Population: A Proof-of-Concept for Quantitative Environmental Surveillance.

COVID-19 SARS-CoV-2 corona sewage surveillance virus concentration wastewater based epidemiology

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2021
Historique:
received: 14 05 2020
accepted: 18 11 2021
entrez: 20 1 2022
pubmed: 21 1 2022
medline: 27 1 2022
Statut: epublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an RNA virus, a member of the coronavirus family of respiratory viruses that includes severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) and the Middle East respiratory syndrome (MERS). It has had an acute and dramatic impact on health care systems, economies, and societies of affected countries during the past 8 months. Widespread testing and tracing efforts are being employed in many countries in attempts to contain and mitigate this pandemic. Recent data has indicated that fecal shedding of SARS-CoV-2 is common and that the virus RNA can be detected in wastewater. This indicates that wastewater monitoring may provide a potentially efficient tool for the epidemiological surveillance of SARS-CoV-2 infection in large populations at relevant scales. In particular, this provides important means of (i) estimating the extent of outbreaks and their spatial distributions, based primarily on in-sewer measurements, (ii) managing the early-warning system quantitatively and efficiently, and (iii) verifying disease elimination. Here we report different virus concentration methods using polyethylene glycol (PEG), alum, or filtration techniques as well as different RNA extraction methodologies, providing important insights regarding the detection of SARS-CoV-2 RNA in sewage. Virus RNA particles were detected in wastewater in several geographic locations in Israel. In addition, a correlation of virus RNA concentration to morbidity was detected in Bnei-Barak city during April 2020. This study presents a proof of concept for the use of direct raw sewage-associated virus data, during the pandemic in the country as a potential epidemiological tool.

Identifiants

pubmed: 35047467
doi: 10.3389/fpubh.2021.561710
pmc: PMC8762221
doi:

Substances chimiques

RNA, Viral 0
Sewage 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

561710

Informations de copyright

Copyright © 2022 Bar-Or, Yaniv, Shagan, Ozer, Weil, Indenbaum, Elul, Erster, Mendelson, Mannasse, Shirazi, Kramarsky-Winter, Nir, Abu-Ali, Ronen, Rinott, Lewis, Friedler, Bitkover, Paitan, Berchenko and Kushmaro.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Infect Dis. 2012 Apr 15;205(8):1294-304
pubmed: 22402037
mSystems. 2020 Jul 21;5(4):
pubmed: 32694130
Environ Sci Technol. 2016 May 17;50(10):5077-85
pubmed: 27111122
Water Sci Technol. 2008;58(4):893-7
pubmed: 18776627
J Appl Microbiol. 2015 Dec;119(6):1729-39
pubmed: 26473649
Lancet Glob Health. 2020 May;8(5):e643
pubmed: 32213325
J Dig Dis. 2020 Mar;21(3):125-126
pubmed: 32096611
Sci Total Environ. 2020 Oct 15;739:139076
pubmed: 32758929
Nat Rev Gastroenterol Hepatol. 2020 May;17(5):259
pubmed: 32214231
Sci Transl Med. 2017 Mar 29;9(383):
pubmed: 28356510
Water Res. 2018 Jun 15;137:220-232
pubmed: 29550725
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):533-534
pubmed: 32246939
Cell Rep Med. 2020 Sep 22;1(6):100098
pubmed: 32904687
Sci Total Environ. 2020 Aug 1;728:138764
pubmed: 32387778
J Water Health. 2007 Mar;5(1):149-62
pubmed: 17402286
Appl Environ Microbiol. 2018 Jul 2;84(14):
pubmed: 29776926
Euro Surveill. 2020 Dec;25(50):
pubmed: 33334397
Lancet Microbe. 2020 May;1(1):e10
pubmed: 32835322
Water Sci Technol. 2005;52(8):213-21
pubmed: 16312970
Nat Med. 2020 Apr;26(4):502-505
pubmed: 32284613

Auteurs

Itay Bar-Or (I)

Central Virology Lab, Ministry of Health, Sheba Medical Center, Jerusalem, Israel.

Karin Yaniv (K)

Avram and Stella Goldstein-Goren, Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Marilou Shagan (M)

Avram and Stella Goldstein-Goren, Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Eden Ozer (E)

Department of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Merav Weil (M)

Central Virology Lab, Ministry of Health, Sheba Medical Center, Jerusalem, Israel.

Victoria Indenbaum (V)

Central Virology Lab, Ministry of Health, Sheba Medical Center, Jerusalem, Israel.

Michal Elul (M)

Central Virology Lab, Ministry of Health, Sheba Medical Center, Jerusalem, Israel.

Oran Erster (O)

Central Virology Lab, Ministry of Health, Sheba Medical Center, Jerusalem, Israel.

Ella Mendelson (E)

Central Virology Lab, Ministry of Health, Sheba Medical Center, Jerusalem, Israel.
School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.

Batya Mannasse (B)

Central Virology Lab, Ministry of Health, Sheba Medical Center, Jerusalem, Israel.

Rachel Shirazi (R)

Central Virology Lab, Ministry of Health, Sheba Medical Center, Jerusalem, Israel.

Esti Kramarsky-Winter (E)

Avram and Stella Goldstein-Goren, Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Oded Nir (O)

Zuckerberg Institute for Water Research (ZIWR), Blaustein Institutes for Desert Research, Ben-Gurion University of the Negev, Sde Boker, Israel.

Hala Abu-Ali (H)

Zuckerberg Institute for Water Research (ZIWR), Blaustein Institutes for Desert Research, Ben-Gurion University of the Negev, Sde Boker, Israel.

Zeev Ronen (Z)

Zuckerberg Institute for Water Research (ZIWR), Blaustein Institutes for Desert Research, Ben-Gurion University of the Negev, Sde Boker, Israel.

Ehud Rinott (E)

Maccabi Healthcare Services, Tel-Aviv, Israel.

Yair E Lewis (YE)

Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Eran Friedler (E)

Faculty of Civil and Environmental Engineering, Technion-Israel Institute of Technology, Haifa, Israel.

Eden Bitkover (E)

Department of Chemical Engineering, Technion-Israel Institute of Technology, Haifa, Israel.

Yossi Paitan (Y)

Clinical Microbiology Laboratory, Meir Medical Center, Kfar Saba, Israel.

Yakir Berchenko (Y)

Department of Industrial Engineering and Management, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Ariel Kushmaro (A)

Avram and Stella Goldstein-Goren, Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel.
The Ilse Katz Center for Meso and Nanoscale Science and Technology, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH